Open methodology · Version 1.0
Skincare Label Clarity Standard
A reproducible 10-point score for how clearly a skincare label communicates the information needed for a product decision.
It measures communication clarity across five dimensions. It does not certify regulatory compliance, product safety, clinical performance, formulation quality, or suitability for one person.
The rubric
Five dimensions. Two points each.
Use only evidence visible on the current package or an official label image for the same market and variant.
Identity and traceability
Can a reader identify the product, its intended cosmetic use, net contents, and responsible company?
- 0 points
- Identity or responsible-party information is unavailable in the reviewed material.
- 1 point
- The product is identifiable, but purpose, quantity, or responsible-party information is incomplete or hard to locate.
- 2 points
- Product identity, intended use, quantity, and responsible-party information are legible and easy to locate.
Ingredient disclosure
Is the current ingredient declaration complete, legible, and attached to the exact product variant?
- 0 points
- No usable ingredient declaration is available.
- 1 point
- A list is present but cropped, difficult to read, outdated, or not clearly tied to the exact variant.
- 2 points
- A complete, legible ingredient declaration is shown for the reviewed market and variant.
Directions for use
Does the label explain where, when, and how the product is intended to be used?
- 0 points
- No practical use directions are available.
- 1 point
- Directions exist but omit important context such as application area, frequency, sequence, or rinse-off status.
- 2 points
- Directions are specific enough to support a practical routine decision without guessing.
Cautions and limits
Are relevant warnings, restrictions, and use limits visible next to the directions or easy to find?
- 0 points
- Relevant caution context is unavailable or contradicted across reviewed surfaces.
- 1 point
- Some caution language is present but vague, separated from use instructions, or difficult to interpret.
- 2 points
- Relevant cautions and use limits are clear, prominent, and consistent with the directions.
Claim specificity
Can a reader distinguish what the product claims from what the label does not establish?
- 0 points
- Claims are unqualified, internally inconsistent, or framed as certainty without usable context.
- 1 point
- The product benefit is understandable, but broad or undefined language makes the evidence boundary unclear.
- 2 points
- Claims are specific, internally consistent, and do not require the reader to infer medical or universal outcomes.
Interpretation
Read the score as a documentation result.
Insufficient evidence
The reviewed material does not support a confident label-based product decision.
Partially clear
Core information exists, but important use or evidence context still requires searching or inference.
Decision-ready
Most information needed for a practical product decision is clear and traceable.
Highly transparent
The reviewed label communicates identity, formula, use, cautions, and claims with minimal ambiguity.
Reproducibility protocol
How to run a defensible benchmark
- Freeze the sample.Record brand, exact product, variant, market, evidence URL, and access date before scoring.
- Score current evidence only.Do not fill gaps from retailer copy, memory, reviews, or a different regional package.
- Keep an evidence note.For every dimension, record the visible text or package surface supporting the score.
- Use two reviewers.For published research, score independently and resolve disagreements against the rubric.
- Publish exclusions.Exclude products when the complete current label cannot be reviewed, and report the number excluded.
- Version every change.Do not compare results across rubric versions without recalculating the complete sample.
Primary references
Regulatory context, not endorsement
The rubric uses FDA labeling resources as factual context for ingredient declarations, identity, warnings, and claim boundaries. Droplet created the clarity score independently; the FDA has not reviewed or endorsed it.
Next release
A benchmark comes after the method.
Droplet will publish aggregate results only after a frozen sample has been independently double-scored with evidence retained for every row. Until then, this page is the method and reusable scorecard, not a claim about the market.